CIP
LFCR icon

Chartwell Investment Partners’s Lifecore Biomedical LFCR Stock Holding History

Chartwell Investment Partners’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-81,233
Closed -$749K – 436
2021
Q3 		$749K Sell
81,233
-1,560
-2% -$17K 0.02% 395
2021
Q2 		$931K Sell
82,793
-1,350
-2% -$15.6K 0.03% 382
2021
Q1 		$892K Sell
84,143
-3,065
-4% -$34.5K 0.03% 368
2020
Q4 		$946K Sell
87,208
-2,794
-3% -$28.9K 0.03% 366
2020
Q3 		$875K Sell
90,002
-7,206
-7% -$68.6K 0.03% 360
2020
Q2 		$774K Sell
97,208
-4,836
-5% -$49.9K 0.03% 351
2020
Q1 		$887K Sell
102,044
-1,921
-2% -$20K 0.04% 331
2019
Q4 		$1.18M Sell
103,965
-420
-0.4% -$4.47K 0.04% 345
2019
Q3 		$1.14M Sell
104,385
-2,765
-3% -$30.1K 0.04% 366
2019
Q2 		$1M Sell
107,150
-8,590
-7% -$86.7K 0.03% 379
2019
Q1 		$1.42M Buy
115,740
+5,291
+5% +$64.6K 0.05% 365
2018
Q4 		$1.31M Sell
110,449
-1,805
-2% -$24.8K 0.05% 384
2018
Q3 		$1.62M Buy
112,254
+5,865
+6% +$81.1K 0.05% 411
2018
Q2 		$1.58M Buy
106,389
+4,066
+4% +$56.5K 0.05% 404
2018
Q1 		$1.33M Sell
102,323
-157,790
-61% -$2.07M 0.05% 347
2017
Q4 		$3.28M Buy
260,113
+73,823
+40% +$933K 0.11% 269
2017
Q3 		$2.41M Sell
186,290
-10,410
-5% -$137K 0.08% 297
2017
Q2 		$2.92M Sell
196,700
-26,500
-12% -$369K 0.11% 242
2017
Q1 		$2.68M Sell
223,200
-44,734
-17% -$566K 0.1% 247
2016
Q4 		$3.7M Sell
267,934
-2,000
-0.7% -$27.7K 0.13% 240
2016
Q3 		$3.62M Sell
269,934
-8,600
-3% -$104K 0.06% 296
2016
Q2 		$3M Buy
+278,534
New +$3.07M 0.05% 293

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Chartwell Investment Partners's LFCR Position: Q4 2021 in Review

Chartwell Investment Partners sold out of Lifecore Biomedical (LFCR) in Q4 2021, closing a stake of 81,233 shares — an estimated $749K sold.

Chartwell Investment Partners first reported a position in LFCR in Q2 2016 and held it in 22 quarters. The position peaked at $3.7M in Q4 2016. 98 funds tracked by Wall St. Rank hold LFCR as of Q4 2021.

  • Chartwell Investment Partners reported no remaining Lifecore Biomedical position as of Q4 2021 after selling out during the quarter.
  • Chartwell Investment Partners sold 81,233 Lifecore Biomedical shares in Q4 2021, an estimated $749K.
  • Chartwell Investment Partners first reported a position in Lifecore Biomedical in Q2 2016 and held it in 22 quarters.
  • Chartwell Investment Partners's Lifecore Biomedical position peaked at $3.7M in Q4 2016.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2021.

Based on Chartwell Investment Partners's 13F filing for Q4 2021, filed 15 Feb 2022.